Literature DB >> 14729742

In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates.

U Pag1, M Oedenkoven, N Papo, Z Oren, Y Shai, H-G Sahl.   

Abstract

OBJECTIVES: Increasing resistance of pathogenic bacteria to antibiotics is a severe problem in health care and has intensified the search for novel drugs. Cationic antibacterial peptides are the most abundant antibiotics in nature and have been frequently proposed as new anti-infective agents. Here, a group of diastereomeric (containing d- and l-amino acids) peptides is studied regarding their potency against multiply resistant clinical isolates and their modes of action against Gram-positive cocci.
METHODS: MIC determinations and chequerboard titrations followed established procedures. Mode of action studies included killing kinetics and a series of experiments designed to characterize the impact of the diastereomeric peptides on bacterial membranes.
RESULTS: The tested diastereomers displayed high antimicrobial and broad spectrum activity with amphipathic-2D being the most active peptide. Synergic activities were observed with individual strains. Mode of action studies clearly demonstrated that the cytoplasmic membrane is a primary target for the peptides and that membrane disruption constitutes a significant bactericidal activity for the major fraction of a bacterial population. However, depending on the indicator strain, the results also suggest that additional molecular events contribute to the overall activity.

Mesh:

Substances:

Year:  2004        PMID: 14729742     DOI: 10.1093/jac/dkh083

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  23 in total

1.  In vitro activity and potency of an intravenously injected antimicrobial peptide and its DL amino acid analog in mice infected with bacteria.

Authors:  Amir Braunstein; Niv Papo; Yechiel Shai
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

2.  Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: effect on mode of action and cell specificity.

Authors:  Igor Zelezetsky; Sabrina Pacor; Ulrike Pag; Niv Papo; Yechiel Shai; Hans-Georg Sahl; Alessandro Tossi
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

3.  Surface-immobilised antimicrobial peptoids.

Authors:  Andrea R Statz; Jong Pil Park; Nathaniel P Chongsiriwatana; Annelise E Barron; Phillip B Messersmith
Journal:  Biofouling       Date:  2008       Impact factor: 3.209

4.  Structure-activity relationships of αs-casein peptides with multifunctional biological activities.

Authors:  Srinivas Sistla
Journal:  Mol Cell Biochem       Date:  2013-08-21       Impact factor: 3.396

5.  Effects of D-Lysine Substitutions on the Activity and Selectivity of Antimicrobial Peptide CM15.

Authors:  Heather M Kaminski; Jimmy B Feix
Journal:  Polymers (Basel)       Date:  2011-12-06       Impact factor: 4.329

6.  Two hits are better than one: membrane-active and DNA binding-related double-action mechanism of NK-18, a novel antimicrobial peptide derived from mammalian NK-lysin.

Authors:  Jiexi Yan; Kairong Wang; Wen Dang; Ru Chen; Junqiu Xie; Bangzhi Zhang; Jingjing Song; Rui Wang
Journal:  Antimicrob Agents Chemother       Date:  2012-10-22       Impact factor: 5.191

7.  Interplay among subunit identity, subunit proportion, chain length, and stereochemistry in the activity profile of sequence-random peptide mixtures.

Authors:  Zvi Hayouka; Saswata Chakraborty; Runhui Liu; Melissa D Boersma; Bernard Weisblum; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2013-08-05       Impact factor: 15.419

8.  Bacteriocin from Bacillus subtilis as a novel drug against diabetic foot ulcer bacterial pathogens.

Authors:  Baby Joseph; Berlina Dhas; Vimalin Hena; Justin Raj
Journal:  Asian Pac J Trop Biomed       Date:  2013-12

9.  Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides.

Authors:  Nathaniel P Chongsiriwatana; James A Patch; Ann M Czyzewski; Michelle T Dohm; Andrey Ivankin; David Gidalevitz; Ronald N Zuckermann; Annelise E Barron
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

Review 10.  Beyond conventional antibiotics - New directions for combination products to combat biofilm.

Authors:  Danir Fanisovich Bayramov; Jennifer Ann Neff
Journal:  Adv Drug Deliv Rev       Date:  2016-08-03       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.